Your session is about to expire
← Back to Search
Cognitive Rehabilitation and Exposure Therapy for Hoarding Disorder (CREST Trial)
N/A
Waitlist Available
Led By Catherine Ayers, PhD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
DSM-5 diagnosis of HD
Adults age 50 and older
Must not have
Current use of benzodiazepine medication
Current or history of any neurodegenerative disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial will help us understand how to better treat hoarding disorder and reduce its negative consequences for those affected, especially older adults.
Who is the study for?
This trial is for adults aged 50 or older who have been diagnosed with Hoarding Disorder (HD) as their primary condition and are stable on medications. They must understand and agree to participate voluntarily. People with current psychosis, substance use disorders, benzodiazepine use, suicidality, neurodegenerative diseases, or those already in exposure therapy cannot join.
What is being tested?
The study tests Cognitive Rehabilitation and Exposure/Sorting Therapy (CREST) combined with Case Management against HD symptoms in older adults. It aims to understand how these treatments work and reduce the severity of hoarding behaviors as well as associated disability.
What are the potential side effects?
While specific side effects are not listed for this psychological intervention, participants may experience increased anxiety or emotional distress during exposure tasks designed to confront hoarding behavior.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with Huntington's disease.
Select...
I am 50 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently taking benzodiazepine medication.
Select...
I have or had a disease that affects my brain or nerves.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Saving Inventory-Revised (SI-R)
Change in Self-report Clutter Image Rating (CIR)
Secondary study objectives
PROMIS-43 Profile v2.
UCSD Performance-Based Skills Assessment (UPSA-2)
UCSD SORT Test (U-SORT)
Other study objectives
Behavior Rating Inventory of Executive Function- Adult Version (BRIEF-A)
Behavioral Avoidance Task (BAT)
DKEFS
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive Rehabilitation and Exposure/Sorting Therapy (CREST)Experimental Treatment1 Intervention
Compensatory Cognitive Training (CCT) Modules (7 sessions). Compensatory Cognitive Training is a manualized, low-tech, cognitive training intervention designed to target cognitive impairments common in people with psychiatric illnesses. The CCT modules specifically selected for CREST map onto known areas of HD neurocognitive impairments and include training in prospective memory, prioritizing, problem solving, planning, and cognitive flexibility.
Exposure to Discarding and Acquiring Modules (19 sessions). Symptoms of acquiring and saving are themselves avoidance behaviors to avoid internal distress related to negative thoughts and emotions. ET utilizes in vivo exposure exercises taking place in the home to enhance generalization of their new skills. Fear hierarchies typically start with a space that has low clutter volume or there is less of an urge to save a particular type of item in that environment.
Group II: Case Management (CM)Active Control1 Intervention
Case Management (CM). CM consists of a set of well-established strategies commonly used in community service settings to address serious and complex problems in particularly vulnerable and often marginalized populations such as those with HD.
Find a Location
Who is running the clinical trial?
University of California, San DiegoLead Sponsor
1,189 Previous Clinical Trials
1,587,591 Total Patients Enrolled
Catherine Ayers, PhDPrincipal InvestigatorUniversity of California, San Diego
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently taking benzodiazepine medication.I have been diagnosed with Huntington's disease.I have or had a disease that affects my brain or nerves.I am 50 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Cognitive Rehabilitation and Exposure/Sorting Therapy (CREST)
- Group 2: Case Management (CM)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.